CAMK2G and cognitive disorder: 5-hydroxymethyl-2-furaldehyde (5-HMF) may block scopolamine-induced learning deficit and enhance cognitive function via the activation of NMDA receptor signaling, including CaMKII and ERK, and would be an effective candidate against cognitive disorders, such as Alzheimer’s disease (Lee et al., 2015).